TEVA PHARMACEUTICAL INDUSTRIES LIMITED

(TEVA)
  Rapport
Temps Différé Nyse  -  20/05 22:00:02
8.470 USD   +1.93%
19/05VENTE D'INITIÉS : Teva Pharmaceutical Industries
MT
18/05Première licence accordée au Royaume-Uni pour le biosimilaire ophtalmologique de Teva, Ongavia (ranibizumab)▼
BU
17/05MISE À JOUR SECTORIELLE : Les actions du secteur de la santé en hausse avant la clôture de mardi
MT
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFonds 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur TEVA PHARMACEUTICAL INDUSTRIES LIMITED
12:50Immuneering Announces Participation in Upcoming Investor Conferences
19/05INSIDER SELL : Teva Pharmaceutical Industries
18/05Teva Announces New Findings Highlighting Potential of ProAir Digihaler (albuterol sulfa..
18/05Teva Pharmaceutical Industries Ltd - United Kingdom first to grant licence for Teva's o..
17/05SECTOR UPDATE : Health Care Stocks Rising Ahead of Tuesday Close
17/05Großbritannien erteilt als erstes Land eine Zulassung für das ophthalmologische Biosimi..
17/05SECTOR UPDATE : Health Care Stocks Firming with Broader Market Gains
17/05SECTOR UPDATE : Health Care
17/05Finding the tipping point
17/05Formycon's Eye Diseases Treatment Receives UK Marketing Authorization
17/05Teva Pharmaceutical's Lucentis Biosimilar Gets UK Regulator Approval
17/05United Kingdom first to grant licence for Teva's ophthalmology biosimilar Ongavia (rani..
17/05Teva Pharmaceutical Industries Limited Welcomes the UK Medicines & Healthcare Regulator..
17/05Teva to Present Latest Research From Neurology Portfolio at the 2022 American Psychiatr..
17/05Teva Announces New Findings Highlighting Potential of ProAir® Digihaler® (albuterol sul..
17/05ANALYST RECOMMENDATIONS : AMD, CarMax, Gilead, J.B. Hunt, Vodafone...
12/05Teva to Present Findings on Short-Acting Beta Agonist (SABA) Use in Asthma Patients and..
10/05TEVA PHARMACEUTICAL INDUSTRIES : Publishes 2021 ESG Progress Report, Showcasing Further In..
10/05Teva Publishes 2021 ESG Progress Report, Showcasing Further Integration of ESG Into Bus..
05/05Walgreens reaches $683 mln opioid settlement with Florida
05/05Walgreens to Pay $683 Million in Florida Opioid Settlement
05/05Immuneering Announces Participation in Citi's Biopharma VIRTUAL Co-Panel Day
03/05TEVA PHARMACEUTICAL INDUSTRIES LTD MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL C..
03/05Teva Pharmaceutical Industries Posts Q1 Adjusted Earnings, Revenue Decline; Maintains F..
03/05TRANSCRIPT : Teva Pharmaceutical Industries Limited, Q1 2022 Earnings Call, May 03, 2022
03/05Teva Reports First Quarter 2022 Financial Results
03/05GUIDANCE : (TEVA) TEVA PHARMACEUTICAL INDUSTRIES LIMITED Forecasts Fiscal Year 2022 Revenu..
03/05Earnings Flash (TEVA) TEVA PHARMACEUTICAL INDUSTRIES LIMITED Posts Q1 EPS $0.55
03/05Earnings Flash (TEVA) TEVA PHARMACEUTICAL INDUSTRIES LIMITED Reports Q1 Revenue $3.66B
03/05Teva Pharmaceutical Industries Limited Reports Earnings Results for the First Quarter E..
03/05Teva Pharmaceutical Industries Limited Announces Impairment Results for the First Quart..
03/05Teva Pharmaceutical Industries Limited Revises Earnings Guidance for the Full Year 2022
02/05Teva Pharmaceutical Affiliates, Lupin Settle Austedo Patent Dispute
02/05Teva Announces Settlement with Lupin Resolving AUSTEDO® (deutetrabenazine) Patent Dispu..
25/04Walgreens, Teva accused of fueling opioid addiction in quest for new markets
20/04Teva Pharmaceutical, MedinCell Receive FDA Complete Response Letter for Application of ..
19/04Teva and MedinCell Receive Complete Response Letter for TV-46000/mdc-IRM
19/04Teva Pharmaceutical Industries Shares Retreat After FDA Rejection Letter
18/04Johnson & Johnson's Janssen Pharmaceutical Reaches $99 Million Opioid Claims Settlement..
11/04Walgreens flooded Florida with addictive opioids, lawyer tells jury
05/04Elon Musk strikes again
05/04Teva Canada Charts a New Prescription for Care
04/04Teva to Host Conference Call to Discuss First Quarter 2022 Financial Results at 8 a.m. ..
04/04Teva to Present New Analyses of AJOVY (fremanezumab-vfrm) Injection and AUSTEDO (deutet..
01/04Teva to Present New Analyses of AJOVY® (fremanezumab-vfrm) Injection and AUSTEDO® (deut..
01/04Immuneering Announces Participation in Piper Sandler AI/ML Investor Conference
31/03Teva Reaches Agreement With Florida to Settle the State's Opioid-Related Claims
30/03Teva Pharmaceutical US Unit Reaches $177 Million Opioid Case Settlement With Florida --..
30/03Florida reaches $878 million opioid settlements with CVS, Teva, others
30/03Teva Pharmaceutical US Unit Reaches Opioid Case Settlement Agreement With Florida; to P..
30/03Teva Reaches Agreement With Florida to Settle the State's Opioid-Related Claims
30/03Teva in Agreement With Florida to Settle Opioid-Related Claims
24/03Immuneering Announces Participation in the 21st Annual Needham Virtual Healthcare Confe..
22/03Pharmapath Sarl acquired Greek Manufacturing Site of Teva Pharmaceutical Industries Lim..
21/03Rhode Island AG Settles With Drug Manufacturers for $28.5 Million, Supply of Opioid Tre..
21/03Rhode Island reaches $107 mln opioid settlements with Teva and Allergan
21/03Teva Pharmaceuticals Agrees to Pay Rhode Island $21 Million, Provide Opioid Treatment O..
21/03Teva Pharmaceutical to Pay $21 Mln Over 13-Years in Settlement with Rhode Island Over O..
21/03Teva Reaches Agreement With Rhode Island to Settle Opioid-Related Claims
17/03Fabricantes de medicamentos genéricos producirán versión barata de píldora de Pfizer pa..
14/03TEVA PHARMACEUTICAL INDUSTRIES : announces donations of essential medicines in support of ..
10/03IMMUNEERING CORP (form 10-K)
09/03INSIDER SELL : Teva Pharmaceutical Industries
09/03INSIDER SELL : Teva Pharmaceutical Industries
09/03INSIDER SELL : Teva Pharmaceutical Industries
09/03INSIDER SELL : Teva Pharmaceutical Industries
09/03Teva Pharmaceutical Industries Limited Reports Earnings Results for the Full Year Ended..
08/03Teva Announces Launch of a First Generic Version of Revlimid (lenalidomide capsules), i..
07/03Teva Pharmaceutical Industries Unit Launches Generic Version of Myeloma Drug Revlimid i..
07/03Teva Announces Launch of a First Generic Version of Revlimid® (lenalidomide capsules), ..
02/03INSIDER SELL : Teva Pharmaceutical Industries
02/03Teva Canada Welcomes Public Drug Plan Reimbursement by Alberta, Saskatchewan, Québec, V..
24/02TEVA PHARMACEUTICAL INDUSTRIES LTD : Change in Directors or Principal Officers (form 8-K)
24/02Teva Pharmaceutical Industries Limited Announces Leaving of Hafrun Fridriksdottir, Exec..
24/02Immuneering Announces Participation in March Investor Conferences
1  2  3  4  5  6  7  8  9  10Suiv.
Prochain événement sur TEVA PHARMACEUTICAL INDUSTRIES LIMITED